Cargando…

The effects of Omarigliptin on promoting osteoblastic differentiation

Osteoporosis significantly impacts the normal life of the elderly and is reported to be closely related to dysfunction of osteoblastic differentiation. Runt-related transcription factor-2 (Runx2) is a critical transcriptional factor involved in the regulation of osteoblast differentiation. Omariglip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Fake, Hu, Xiunian, Chen, Rijiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809961/ https://www.ncbi.nlm.nih.gov/pubmed/34787070 http://dx.doi.org/10.1080/21655979.2021.1999366

Ejemplares similares

Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse
por: Li, Xiaoyan, et al.
Publicado: (2022)

Aucubin exerts anti-osteoporotic effects by promoting osteoblast differentiation
por: Li, Yutong, et al.
Publicado: (2020)

Omarigliptin inhibits brain cell ferroptosis after intracerebral hemorrhage
por: Zhang, Yan, et al.
Publicado: (2023)

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
por: Ayoub, Bassam M., et al.
Publicado: (2018)

Omarigliptin Protects the Integrity of the Blood–Brain Barrier After Intracerebral Hemorrhage in Mice
por: Zhang, Yan, et al.
Publicado: (2023)

Sulfuretin promotes osteoblastic differentiation in primary cultured osteoblasts and in vivo bone healing
por: Auh, Q-Schick, et al.
Publicado: (2016)

Omarigliptin decreases inflammation and insulin resistance in a pleiotropic manner in patients with type 2 diabetes
por: Hattori, Sachiko
Publicado: (2020)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
por: Hattori, Sachiko, et al.
Publicado: (2021)

Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2021)

A randomised, double‐blind, trial of the safety and efficacy of omarigliptin (a once‐weekly DPP‐4 inhibitor) in subjects with type 2 diabetes and renal impairment
por: Chacra, Antonio, et al.
Publicado: (2017)

Correction for: Aucubin exerts anti-osteoporotic effects by promoting osteoblast differentiation
por: Li, Yutong, et al.
Publicado: (2021)

Enhanced Extraction Technique of Omarigliptin from Human Plasma—Applied to Biological Samples from Healthy Human Volunteers
por: Mowaka, Shereen, et al.
Publicado: (2020)

ATF4 Promotes β-Catenin Expression and Osteoblastic Differentiation of Bone Marrow Mesenchymal Stem Cells
por: Yu, Shibing, et al.
Publicado: (2013)

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation
por: Liu, Fei-Lan, et al.
Publicado: (2017)

Static magnetic fields promote osteoblastic/cementoblastic differentiation in osteoblasts, cementoblasts, and periodontal ligament cells
por: Kim, Eun-Cheol, et al.
Publicado: (2017)

Efficacy and Patient Satisfaction of the Weekly DPP-4 Inhibitors Trelagliptin and Omarigliptin in 80 Japanese Patients with Type 2 Diabetes
por: Tosaki, Takahiro, et al.
Publicado: (2017)

Differentiated osteoblasts derived decellularized extracellular matrix to promote osteogenic differentiation
por: Jeon, Jin, et al.
Publicado: (2018)

Nampt promotes osteogenic differentiation and lipopolysaccharide-induced interleukin-6 secretion in osteoblastic MC3T3-E1 cells
por: He, Shan, et al.
Publicado: (2021)

Simultaneous Quantification of Pioglitazone and Omarigliptin in Rat Plasma by UHPLC-MS/MS and Its Application to Pharmacokinetic Study after Coadministration of the Two Drugs
por: Wang, Lin, et al.
Publicado: (2021)

Artificial Extracellular Matrices with Oversulfated Glycosaminoglycan Derivatives Promote the Differentiation of Osteoblast-Precursor Cells and Premature Osteoblasts
por: Hempel, Ute, et al.
Publicado: (2014)

IL-21 promotes osteoblastic differentiation of human valvular interstitial cells through the JAK3/STAT3 pathway
por: Liu, Zongtao, et al.
Publicado: (2020)

mTORC1 Signaling Promotes Osteoblast Differentiation from Preosteoblasts
por: Chen, Jianquan, et al.
Publicado: (2015)

Betaine promotes cell differentiation of human osteoblasts in primary culture
por: Villa, Isabella, et al.
Publicado: (2017)

Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer
por: Ye, Yun, et al.
Publicado: (2017)

Analytical quality-by-design approach for development and validation of HPLC method for the simultaneous estimation of omarigliptin, metformin, and ezetimibe: application to human plasma and dosage forms
por: Magdy, Galal, et al.
Publicado: (2023)

Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathway
por: Saeed, Hamid, et al.
Publicado: (2015)

GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells
por: Gu, Zhengtao, et al.
Publicado: (2020)

Tridax procumbens flavonoids promote osteoblast differentiation and bone formation
por: Al Mamun, Md. Abdullah, et al.
Publicado: (2015)

CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation
por: Li, Xueni, et al.
Publicado: (2008)

Sesamin Promotes Osteoblastic Differentiation and Protects Rats from Osteoporosis
por: Ma, Zhong-ping, et al.
Publicado: (2019)

Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis
por: Park, See-Hyoung, et al.
Publicado: (2020)

Monocarboxylate transporter-1 promotes osteoblast differentiation via suppression of p53, a negative regulator of osteoblast differentiation
por: Sasa, Kiyohito, et al.
Publicado: (2018)

The efficacy and safety of once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
por: Wang, Xianying, et al.
Publicado: (2018)

Zinc finger protein ZFP36L1 promotes osteoblastic differentiation but represses adipogenic differentiation of mouse multipotent cells
por: Tseng, Kuo-Yun, et al.
Publicado: (2017)

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus
por: Gantz, Ira, et al.
Publicado: (2017)

Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once‐weekly dipeptidyl peptidase‐4 inhibitor, in healthy Japanese men
por: Tsuchiya, Saori, et al.
Publicado: (2016)

Omarigliptin Mitigates 6-Hydroxydopamine- or Rotenone-Induced Oxidative Toxicity in PC12 Cells by Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Actions
por: Gouda, Noha A., et al.
Publicado: (2022)

Lactate-induced histone lactylation by p300 promotes osteoblast differentiation
por: Minami, Erika, et al.
Publicado: (2023)

RETRACTED ARTICLE: Titanium particles damage osteocytes and inhibit osteoblast differentiation
por: Chen, Li, et al.
Publicado: (2020)

Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines
por: Zhang, Chunfang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u6b2fv6vira318c3734jaerod2